Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...
Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...
Increasing numbers of patients require aortic valve surgery ... either a homograft or the pretreated stentless xenograft bioprosthesis. Survival of patients after 8 years was about 80% for ...
Hosted on MSN2mon
Mechanical valves offer superior long-term survival for aortic valve replacement patients aged 60, study finds"The decision between a bioprosthetic and a mechanical valve is one of the most consequential for patients requiring aortic valve replacement," said Dr. Michael Bowdish, lead author of the study ...
aHR 1.12 favoring bioprosthetic valves (95% CI 0.97-1.29) These findings were consistent in sensitivity analyses excluding pure aortic insufficiency, intermediate- or high-risk patients ...
but with less risk of bioprosthetic valve dysfunction, in patients with small annuli and symptomatic severe aortic stenosis. Presenting the data here at CRT 2025, SMART lead Investigator Howard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback